President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026. Alex Wong/Getty Images
Regeneron Pharmaceuticals on April 23 became the latest drug manufacturer to enter a Most Favored Nation drug pricing agreement with the United States.
President Donald Trump announced the deal from the Oval Office.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.